Cancer-focused clinical trials become ever more difficult to execute, finds a new study sponsored by the Tufts Center for the Study of Drug Development (CSDD). Why? It’s…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.